Skip to main content
Lynn Howie, MD, Oncology, Asheville, NC

LynnJacksonHowieMD

Oncology Asheville, NC

Breast Cancer, Hematologic Oncology

Oncologist

Dr. Howie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Howie's full profile

Already have an account?

  • Office

    Not applicable
    Asheville, NC 28803

Summary

  • Dr. Lynn Howie is an oncologist in Hendersonville, NC and is affiliated with multiple hospitals in the area, including Margaret R. Pardee Memorial Hospital and Charles George Veterans Affairs Medical Center. She received her medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 8 years. She specializes in breast cancer and hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2009 - 2012
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2009

Certifications & Licensure

  • HI State Medical License
    HI State Medical License 2020 - 2026
  • NC State Medical License
    NC State Medical License 2012 - 2025
  • DC State Medical License
    DC State Medical License 2016 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha 2008

Publications & Presentations

PubMed

Press Mentions

  • Older Women with HR-Positive Breast Cancer May Receive Similar Benefit from CDK 4/6 Inhibitors as Younger Women
    Older Women with HR-Positive Breast Cancer May Receive Similar Benefit from CDK 4/6 Inhibitors as Younger WomenDecember 8th, 2017